¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"limiting factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
phantom scatter factor
ÆÒÅÒ»ê¶õ°è¼ö
quality factor
1. Áú¿ä¼Ò 2. Á¤¼ºÀÎÀÚ
racial factor
ÀÎÁ¾¿äÀÎ
realization factor
½ÇÇöÀÎÀÚ
recruitment factor
µ¿¿øÀÎÀÚ
reducing factor
ȯ¿øÀÎÀÚ
reinforcing factor
°È¿äÀÎ
relaxing factor
ÀÌ¿ÏÀÎÀÚ
radiation weighting factor
¹æ»ç¼±°¡Áß°è¼ö
resistance factor
³»¼ºÀÎÀÚ, ÀúÇ×ÀÎÀÚ
resistance transfer factor
³»¼ºÀü´ÞÀÎÀÚ
reticuloendothelial depressant factor
±×¹°³»Çǰè¾ïÁ¦ÀÎÀÚ, ¸Á»ó³»Çǰè¾ïÁ¦ÀÎÀÚ
rheumatoid factor
·ù¸¶Æ¼½ºÀÎÀÚ
risk factor
À§ÇèÀÎÀÚ
roentgen-to-rad conversion factor
·ÛÆ®°Õ´ë·¡µåº¯È¯°è¼ö
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
safety factor
¾ÈÀü°è¼ö
scatter factor
»ê¶õ°è¼ö
sebotropic factor
Áö·çÃËÁøÀÎÀÚ
skin vascular permeability factor
ÇǺÎÇ÷°üÅõ°úÀÎÀÚ
somatotropin release inhibiting factor
¼ºÀåÈ£¸£¸óÀ¯¸®¾ïÁ¦ÀÎÀÚ
spreading factor
È®»êÀÎÀÚ
stable factor
¾ÈÁ¤ÀÎÀÚ
stroma factor
¹öÆÀÁúÀÎÀÚ
sunprotective factor
Àϱ¤º¸È£Áö¼ö
testis-determining factor
°íȯ°áÁ¤ÀÎÀÚ
therapeutic gain factor
Ä¡·áÀ̵æ°è¼ö
thyrotrophin releasing factor
¹æÆÐ»ùÀÚ±ØÈ£¸£¸óÀ¯¸®ÀÎÀÚ, °©»ó»ùÀÚ±ØÈ£¸£¸óÀ¯¸®ÀÎÀÚ
time-dose factor
½Ã°£¼±·®ÀÎÀÚ
tissue factor
Á¶Á÷ÀÎÀÚ
transfer factor
Àü´ÞÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
plasma thromboplastin factor
Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ.
platelet activating factor
Ç÷¼ÒÆÇ Ȱ¼º ÀÎÀÚ
platelet factor 4
Ç÷¼ÒÆÇÀÎÀÚ(úìá³÷ùì×í) 4
platelet factor 4=PF4
Ç÷¼ÒÆÇÀÎÀÚ 4
platelet factor III
Ç÷¼ÒÆÇÁ¦»ïÀÎÀÚ.
platelet-activating factor (PAF)
Ç÷¼ÒÆÇ Ȱ¼ºÈÀÎÀÚ
platelet-activating factor (paf)
Ç÷¼ÒÆÇȰ¼ºÈÀÎÀÚ(úìá³÷ùüÀàõûùì×í)
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡ Áõ½ÄÀÎÀÚ
platelet-derived growth factor(PDGF)
Ç÷¼ÒÆÇ À¯·¡ ¼ºÀå ÀÎÀÚ
platelet-derived growth factor(pdgf)
ÆÇ-À¯µµ¼ºÀåÀÎÀÚ(úìá³÷ù-ë¯Óôà÷íþì×í)
power factor
Ãâ·Â·ü(õóæ³ëÒ), ¿ª·ü(æ³ëÒ).
predisposing factor
¼ÒÀμº ¿äÀÎ, ¼±Çà¿äÀÎ.
prognostic factor
¿¹ÈÄÀÎÀÚ
prolactin inhibiting factor
ÇÁ·Ñ¶ôƾ(ºÐºñ)¾ïÁ¦ÀÎÀÚ.
prolactin inhibiting factor
ÇÁ·Î¶ôƾ¾ïÁ¦ÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
dilution factor
¹±ÈûÀÎÀÚ(¡ì×í), Èñ¼®ÀÎÀÚ.
dose conversion factor
¼±·®º¯È¯°è¼ö
dose modifying factor
¼±·®¼ö½Ä°è¼ö
dose-reduction factor
¼±·®°¨¼Ò°è¼ö
drug resistance factor
¾àÁ¦³»¼ºÀÎÀÚ
drug resistance transfer factor
¾àÁ¦³»¼ºÀü´ÞÀÎÀÚ
duplicate factor
Áߺ¹ÀÎÀÚ.
early pregnancy factor(EPF)
ÃʱâÀÓ½ÅÀÎÀÚ
edaphic factor
ÅäÁöÀÎÀÚ(ÊÙËöËö).
elongation factor
¿¬ÀåÀÎÀÚ(¡ì×í).
elongation factor
½ÅÀåÀÎÀÚ
enabling factor
ÀÇ·áÀÌ¿ë °¡´É¿äÀÎ.
encephalitogenic factor
³ú¿°À¯¹ßÀÎÀÚ
encephalitogenic factor
³ú¿°À¯¹ßÀÎÀÚ.
endothelial cell growth factor
³»ÇǼ¼Æ÷ Áõ½ÄÀÎÀÚ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
9
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½